Maravai Lifesciences Reports First Quarter Financial Results and Updates 2021 Financial Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
- Meta’s new Class C stock to keep Zuckerberg in California, fund AI spending spree
- Oil hits five-month high as Houthi attacks stoke supply fears
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- Abbott plans to spin off its nutrition unit as a standalone public company
- Alphabet shares drop ahead of earnings next week
- AMD shares fall amid AI chip sector selloff
- Bloom Energy Corp. (BE) Tops Q3 EPS by 25c, Beats on Revenue; Offers FY26 Guidance
- JetBlue shares fall amid American results, fuel cost concerns
Maravai LifeSciences (MRVI) Tops Q1 EPS by 4c
May 10, 2021 4:20 PM EDTMaravai LifeSciences (NASDAQ: MRVI) reported Q1 EPS of $0.24, $0.04 better than the analyst estimate of $0.20. Revenue for the quarter came in at $148.2 million versus the consensus estimate of $138.49 million.
GUIDANCE:
Maravai LifeSciences sees FY2021 EPS of $1.04-$1.12, versus the consensus of $0.89.... More



